{
}
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Cardinal Health's CEO Jason M. Hollar sold 46,455 shares for approximately $5.06 million, while CFO Aaron E. Alt sold 2,323 shares valued at about $253,000, both transactions reflecting a 0.00% decrease in their positions. Insiders have sold a total of 113,963 shares worth $12.38 million in the last ninety days, with institutional investors holding 87.17% of the stock. UBS Group raised its price target for Cardinal Health from $125 to $134, indicating a potential upside of 19.79%.
Cullen Frost Bankers Inc. and Compagnie Lombard Odier SCmA each acquired new stakes in Apollo Global Management valued at approximately $35,000. J.Safra Asset Management Corp significantly increased its position by 709.3%, now holding shares worth $39,000, while Massmutual Trust Co. FSB ADV raised its stake by 293.2%, owning shares valued at $55,000. Institutional investors control 77.06% of the stock, which has a "Moderate Buy" rating and a consensus target price of $139.56, despite a recent dip in share price.
Price T Rowe Associates Inc. increased its stake in StepStone Group, owning 850,463 shares valued at $30.4 million after acquiring 510,283 shares. Dimensional Fund Advisors LP also raised its holdings by 8.1%, now owning 800,909 shares worth $36.8 million. Institutional investors hold 55.54% of the stock, while UBS Group raised its price target for StepStone from $55 to $65, indicating a potential upside of 9.19%.
Otsuka Pharmaceutical's experimental drug, sibeprenlimab, has shown promising results in a Phase 3 trial for IgA nephropathy, a rare kidney disease, demonstrating a significant reduction in protein levels in urine, a key indicator of kidney health. The company plans to discuss accelerated approval with the FDA while the trial continues, expected to conclude in early 2026. This development validates Otsuka's acquisition of Visterra, which focuses on immune diseases, and positions sibeprenlimab as a potential first-in-class treatment for IgAN.
The Swiss stock exchange SIX has signed a Memorandum of Understanding with the China Construction Bank Corporation (CCB) to enhance cooperation in securities services and product development. This partnership aims to explore new business opportunities as Chinese firms increasingly view Switzerland as an alternative to U.S. exchanges. UBS, which holds a significant stake in SIX, is driving this initiative amid a challenging environment marked by delistings.
US Treasuries are under pressure due to rising global public debt and increased odds of a Trump presidency, with markets anticipating higher Treasury supply from a growing deficit. Despite this volatility, the macroeconomic environment remains favorable for fixed income, supported by a resilient economy and expected interest rate cuts from the Fed, which could lower Treasury yields. Investment-grade corporate bonds are projected to deliver solid returns, prompting a recommendation for investors to allocate excess cash into quality fixed income assets.
JPMorgan and Goldman Sachs have differing outlooks on the US stock market's future. While JPMorgan anticipates a solid run for stocks, Goldman Sachs warns of a modest 3% annual return, citing high starting valuations and elevated Treasury yields that may divert investment into bonds and other assets.
BlackRock has launched two new exchange-traded funds (ETFs) to provide investors with exposure to the rapidly growing artificial intelligence market. The asset management giant views AI as a significant investment theme with long-term implications across various industries. With over 1,400 ETFs and $4.2 trillion in assets under management, BlackRock aims to capitalize on the increasing popularity of thematic investing.
The global convergence in healthcare market is projected to grow from $126.2 billion in 2023 to $304.5 billion by 2031, with a CAGR of 11.78%. North America leads this market due to its advanced healthcare infrastructure, while Europe is expected to experience the fastest growth driven by rising coronary artery disease rates. Recent innovations include real-time health monitoring systems and integrated patient monitoring solutions from major companies like Philips and Honeywell.
As the US economy shifts towards a "no-landing" scenario, private equity is expected to regain its lead over public equities, despite recent underperformance. With valuations stabilizing and borrowing costs likely to fall, discerning investors may find better opportunities in private equity, which historically outperforms public stocks by 2.5 percentage points over the business cycle. Additionally, alternative assets like private infrastructure and debt can enhance portfolio diversity and resilience.
USA
Country
16:52 22.10.2024
Riverview Trust Co
Massmutual Trust Co. FSB ADV
Cullen/Frost Bankers, Inc.
J.Safra Asset Management Corp
Compagnie Lombard Odier SCmA
USA
Pauline Richards
Show more
16:52 22.10.2024
StepStone Group Inc.
USA
Oppenheimer
Price T Rowe
UBS Group
Goldman Sachs Group
Dimensional Fund Advisors
Show more
16:52 22.10.2024
Travere Therapeutics, Inc.
Biogen Inc.
Q32 Bio Inc.
Otsuka Pharmaceutical Co. Ltd.
Calliditas Therapeutics AB (publ)
Vera Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated
Novartis AG
JPN
USA
Brian Pereira
John Kraus
Show more
16:51 22.10.2024
16:50 22.10.2024
United States Dollar
USA
Solita Marcelli
Mark Haefele
Frederick Mellors
Daisy Tseng
Vincent Heaney
Show more
16:48 22.10.2024
United States Dollar
JPMorgan Chase & Co.
The Goldman Sachs Group, Inc.
USA
Goldman Sachs
JPMorgan Chase
16:48 22.10.2024
16:18 22.10.2024
United States Dollar
Koninklijke Philips N.V.
GE HealthCare Technologies Inc.
Honeywell International Inc.
BioSig Technologies, Inc. Common Stock
USA
BRA
IND
KOR
ESP
ZAF
MEX
FRA
GBR
CAN
ITA
JPN
DEU
CHN
ARG
Koninklijke Philips N.V.
Honeywell International Inc.
InsightAce Analytic
Inc.
GE Healthcare
PreXion
Show more
16:15 22.10.2024
16:11 22.10.2024
Trending
Subcategory:
Cryptocurrency Markets
Stock Market Updates
Cryptocurrency Trends
Cryptocurrency & Blockchain Regulations
Central Bank Actions
Market Sentiment Analysis
Banking & Investment Regulations
Employment Reports
Banking Regulations
Corporate Responsibility & ESG
Anti-Money Laundering (AML) Regulations
Inflation Rates & CPI Data
Blockchain Technology Adoption
Hedge Funds & Private Equity
Cryptocurrency Regulations
Tokenomics and Crypto Economics
Decentralized Finance (DeFi) Innovations
Mergers & Acquisitions
Emerging Startups
Cryptocurrency Developments
Countries:
Companies:
Currencies:
People:
Coinbase Global, Inc.
Apple Inc.
NVIDIA Corporation
Solana USD
Ethereum USD
Tesla, Inc.
Chainlink USD
Bitwise Bitcoin ETF
Fidelity Contrafund
UBS Group AG
BlackRock, Inc.
MicroStrategy Inc
Delta Air Lines, Inc.
Kraken Energy Corp.
Ripple USD USD
Ripples USD
Microsoft Corporation
Standard Chartered PLC
Novartis AG
Bank of America Corporation
United States Dollar
Euro
Swiss Franc
British Pound Sterling
Japanese Yen
Indian Rupee
Swedish Krona
Chinese Yuan
Canadian Dollar
Singapore Dollar
South Korean Won
New Taiwan Dollar
Thai Baht
Philippine Peso
Russian Ruble
Vietnamese Đồng
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.